ImpRovEd Care After eSophageCtomy Using an Algorithm for postoperativE Complications - RESCUE Trial

NCT06762652 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1050

Last updated 2025-01-07

No results posted yet for this study

Summary

The objective of the RESCUE-trial is to investigate whether implementation of a consensus-based clinical care algorithm to standardize diagnosis and management of postoperative complications reduces 90-day mortality, ICU (re)admission and surgical interventions after esophagectomy for esophageal cancer.

Conditions

  • Diagnosis and Treatment of Complications After Esophagectomy

Interventions

OTHER

Wash-in period

The goal of the wash-in period between the control and intervention period is to intensively educate and train physicians to use the algorithm as intended during daily postoperative care. The coordinating investigator along with the local principal investigator will be responsible for this training. Training will be performed in a standardized approach in order to guarantee uniformity across centres.

DIAGNOSTIC_TEST

Algorithm-based care

During the intervention period, (participating) patients will receive algorithm-based care. The RESCUE algorithm is a consensus-based clinical care algorithm developed to standardize postoperative care. The algorithm includes the same modalities as applied in usual care, and does not include novel/experimental modalities, but rather offers a novel, standardized approach to guide the use of common modalities during postoperative care. The daily objective evaluation of patients' condition, vital signs and biochemical parameters is thought to aid early diagnosis of complications after esophagectomy which enables treatment before systemic symptoms become apparent and prevent development of sepsis. Physicians are always allowed to deviate from the RESCUE, but reasons for deviating will be recorded.

Sponsors & Collaborators

  • Catharina Ziekenhuis Eindhoven

    collaborator OTHER
  • Erasmus Medical Center

    collaborator OTHER
  • University Medical Center Groningen

    collaborator OTHER
  • Hospital Group Twente (ZGT)

    collaborator UNKNOWN
  • Antoni van Leeuwenhoek Hospital

    collaborator OTHER
  • Leiden University Medical Center

    collaborator OTHER
  • Elisabeth-TweeSteden Ziekenhuis

    collaborator OTHER
  • medical center leeuwarden

    collaborator UNKNOWN
  • Zuyderland Medical Centre

    collaborator OTHER
  • Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

    collaborator OTHER
  • Reinier de Graaf Groep

    collaborator OTHER
  • Gelre Hospitals

    collaborator OTHER
  • UMC Utrecht

    collaborator OTHER
  • Radboud University Medical Center

    lead OTHER

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-06-01
Primary Completion
2027-07-01
Completion
2028-07-01

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06762652 on ClinicalTrials.gov